Author details

Full Name

Choh Yeung

Affiliation

Center for Cancer Research, National Cancer Institute

ORCID

Career Start Year

1987

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37616468	Inhibition of NAD+-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models.	Clin Cancer Res	2023
37616468	Inhibition of NAD+-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models.	Clin Cancer Res	2023
32354737	Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma.	Cancer Res	2020
32354737	Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma.	Cancer Res	2020
32908120	Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma.	Oncogenesis	2020
32908120	Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma.	Oncogenesis	2020
31431459	Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma.	Cancer Res	2019
31431459	Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma.	Cancer Res	2019
27835791	The Role of PDGFR-Î² Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma.	Transl Oncol	2016
27835791	The Role of PDGFR-Î² Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma.	Transl Oncol	2016
25925378	IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma.	Neoplasia	2015
25925378	IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma.	Neoplasia	2015
24277455	Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth.	Clin Cancer Res	2014
24277455	Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth.	Clin Cancer Res	2014
23318429	Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth.	Oncogene	2013
23318429	Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth.	Oncogene	2013
22495974	Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer.	Horm Metab Res	2012
22495974	Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer.	Horm Metab Res	2012
23002205	Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma.	Cancer Res	2012
23002205	Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma.	Cancer Res	2012
21403840	Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells.	Neoplasia	2011
21403840	Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells.	Neoplasia	2011
21653923	Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.	J Natl Cancer Inst	2011
21653923	Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.	J Natl Cancer Inst	2011
19809159	Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.	J Clin Invest	2009
19597468	Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin.	Oncogene	2009
19809159	Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.	J Clin Invest	2009
19597468	Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin.	Oncogene	2009
18071913	Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases.	Clin Exp Metastasis	2008
18071913	Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases.	Clin Exp Metastasis	2008
17409454	Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival.	Cancer Res	2007
17409454	Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival.	Cancer Res	2007
14704791	The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.	Nat Med	2004
14704791	The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.	Nat Med	2004
11325848	Metastasis-associated differences in gene expression in a murine model of osteosarcoma.	Cancer Res	2001
11325848	Metastasis-associated differences in gene expression in a murine model of osteosarcoma.	Cancer Res	2001
10987281	XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma.	Cancer Res	2000
18521287	Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein.	Sarcoma	2000
10987281	XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma.	Cancer Res	2000
11315100	An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential.	Clin Exp Metastasis	2000
18521287	Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein.	Sarcoma	2000
11315100	An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential.	Clin Exp Metastasis	2000
10224065	Diminished G1 checkpoint after gamma-irradiation and altered cell cycle regulation by insulin-like growth factor II overexpression.	J Biol Chem	1999
10224065	Diminished G1 checkpoint after gamma-irradiation and altered cell cycle regulation by insulin-like growth factor II overexpression.	J Biol Chem	1999
8341365	Induction and suppression of proto-oncogenes in rat striatum after single or multiple treatments with cocaine or GBR-12909.	NIDA Res Monogr	1993
8314788	Production of recombinant cytochrome b558 allows reconstitution of the phagocyte NADPH oxidase solely from recombinant proteins.	J Biol Chem	1993
8341365	Induction and suppression of proto-oncogenes in rat striatum after single or multiple treatments with cocaine or GBR-12909.	NIDA Res Monogr	1993
8314788	Production of recombinant cytochrome b558 allows reconstitution of the phagocyte NADPH oxidase solely from recombinant proteins.	J Biol Chem	1993
1318579	Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase.	Science	1992
1318579	Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase.	Science	1992

1 - 50 of 52

Jinu Abraham

Oregon Health & Science University

Career Start Year 2010

Number of shared co-authors 4

Thomas G P Gr??newald

German Cancer Research Center

Career Start Year 2006

Number of shared co-authors 6

Joseph A Ludwig

The University of Texas MD Anderson Cancer Center

Career Start Year 2005

Number of shared co-authors 4

Didier Surdez

Balgrist University Hospital, University of Zurich (UZH)

Career Start Year 2005

Number of shared co-authors 4

Ken Kikuchi

Kyoto Prefectural University of Medicine

Career Start Year 2002

Number of shared co-authors 2

Robert Cornelison

University of Virginia

Career Start Year 2000

Number of shared co-authors 3

Oscar M Tirado

Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC

Career Start Year 2000

Number of shared co-authors 3

Christopher D Willey

University of Alabama at Birmingham

Career Start Year 2000

Number of shared co-authors 0

Jan Koster

Amsterdam University Medical Centers location AMC

Career Start Year 1999

Number of shared co-authors 2

John D Gordan

Quantitative Biosciences Institute (QBI), University of California San Francisco

Career Start Year 1996

Number of shared co-authors 0

Kimberly Stegmaier

Dana-Farber Cancer Institute

Career Start Year 1995

Number of shared co-authors 6

Cristina E Tognon

Knight Cancer Institute, Oregon Health & Science University

Career Start Year 1993

Number of shared co-authors 0

Andrei Goga

University of California San Francisco

Career Start Year 1993

Number of shared co-authors 0

Enrique de Alava

Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.

Career Start Year 1992

Number of shared co-authors 4

Aykut Uren

Georgetown University Medical Center

Career Start Year 1991

Number of shared co-authors 11

John Easton

St Jude Children's Research Hospital

Career Start Year 1991

Number of shared co-authors 4

Simone Hettmer

University Medical Center Freiburg, University of Freiburg

Career Start Year 1990

Number of shared co-authors 4

Poul H Sorensen

British Columbia Cancer Research Centre

Career Start Year 1989

Number of shared co-authors 8

E Alejandro Sweet-Cordero

University of California San Francisco

Career Start Year 1989

Number of shared co-authors 5

Dirk Geerts

Amsterdam University Medical Center

Career Start Year 1989

Number of shared co-authors 0

Todd R Golub

Broad Institute of MIT and Harvard

Career Start Year 1989

Number of shared co-authors 1

Wei Zhang

The University of Texas MD Anderson Cancer Center

Career Start Year 1988

Number of shared co-authors 0

Lori S Hart

Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research

Career Start Year 1987

Number of shared co-authors 3

Katia Scotlandi

IRCCS Istituto Ortopedico Rizzoli

Career Start Year 1987

Number of shared co-authors 7

David M Loeb

Children's Hospital at Montefiore.

Career Start Year 1986

Number of shared co-authors 3

Jeffrey A Toretsky

Georgetown University Medical Center, Georgetown University

Career Start Year 1986

Number of shared co-authors 7

Susan A Burchill

Leeds Institute of Medical Research, St. James's University Hospital

Career Start Year 1986

Number of shared co-authors 1

Beat W Sch??fer

Department of Oncology and Children's Research Center, University Children's Hospital

Career Start Year 1985

Number of shared co-authors 6

John A Copland

Mayo Clinic Jacksonville

Career Start Year 1982

Number of shared co-authors 2

Charles Keller

Children's Cancer Therapy Development Institute

Career Start Year 1980

Number of shared co-authors 6

row(s) 1 - 30 of 30

Lee J Helman

Osteosarcoma Institute

Co-authored papers 20

Arnulfo Mendoza

National Cancer Institute, National Institutes of Health

Co-authored papers 11

Chand Khanna

National Cancer Institute, National Institutes of Health

Co-authored papers 10

Javed Khan

Center for Cancer Research, National Cancer Institute

Co-authored papers 6

Patrick J Grohar

Children's Hospital of Philadelphia.

Co-authored papers 4

Qing-Rong Chen

Center for Biomedical Informatics and Information Technology

Co-authored papers 3

Stephen M Hewitt

Center for Cancer Research, National Cancer Institute

Co-authored papers 3

Louis M Staudt

National Cancer Institute, National Institutes of Health

Co-authored papers 3

Laurie B Griffin

University of Michigan ann arbor

Co-authored papers 2

Duane G Currier

St. Jude Children's Research Hospital

Co-authored papers 2

Jack F Shern

Co-authored papers 2

Yves Pommier

Center for Cancer Research, National Cancer Institute

Co-authored papers 2

Sandra Burkett

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 1

Itay Bentov

University of Washington

Co-authored papers 1

James G Taylor

Center for Sickle Cell Disease, Howard University College of Medicine

Co-authored papers 1

Stephen J Chanock

National Cancer Institute, National Institutes of Health

Co-authored papers 1

Stephen R Plymate

University of Washington

Co-authored papers 1

Glenn Merlino

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 1

James B McMahon

Center for Cancer Research, National Cancer Institute

Co-authored papers 1

Lance A Liotta

Co-authored papers 1

Girma M Woldemichael

Center for Cancer Research, National Cancer Institute

Co-authored papers 1

Victor M Darley-Usmar

University of Alabama at Birmingham

Co-authored papers 1

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 1

Susan R Davis

Co-authored papers 1

Jun S Wei

Center for Cancer Research, National Cancer Institute

Co-authored papers 1

Gloria A Benavides

University of Alabama at Birmingham

Co-authored papers 1

Young K Song

National Cancer Institute, National Institutes of Health

Co-authored papers 1